Continuity as a
research instrument
Certificate of registration · MD 0020059
16 October 1992
The original state registration certificate for FIRMA TEHNOFARM S.R.L., issued by Camera Înregistrării de Stat of the Republic of Moldova.
State identification number — codul fiscal — 1005600002358, the same identifier under which the company operates today. Thirty-three years of continuous mandate begin with this single page.
Download original certificate (1992)TEHNOFARM S.R.L. was established in October 1992 and has operated continuously as a pharmaceutical, biotechnology, and information-technology entity in the Republic of Moldova ever since. The company holds sixty registered activity codes across pharmaceutical production, biotechnology R&D, cosmetic manufacturing, agricultural raw-material processing, and information services — a deliberately broad operational mandate maintained across three decades of changing economic and regulatory environments in the region.
What matters about thirty-three years of continuous operation is not a year-by-year inventory of activities. What matters is what continuity makes possible.
Continuity as a research instrument
Thirty-three years is long enough to observe full agricultural and pharmaceutical cycles in their unhurried form. Plant material that requires seven years from cultivar selection to industrial leaf yield — ginkgo. Saffron fields that need four full seasons to express their pharmacological profile under a specific microclimate. Walnut programmes whose phytochemical optima emerge across a decade of leaf-harvest data. A short-cycle operation cannot run these experiments. A continuous operator can — and the company has.
Continuity as an institutional habit
The pharmaceutical, biotechnology, and information-technology mandate registered in 1992 has been kept active not as a paper formality but as a working discipline. Records have accumulated. Working relationships with regulatory bodies, suppliers, and partner institutions have aged into trust. The 2026 corporate restructuring into the TF Group — TF Holding parent, TEHNOFARM operational subsidiary, NORD NUC field operator, TF Assets infrastructure, TF Intelligence Platform software and IP entity — was a formalisation of operational reality, not the start of operations.
Continuity as the foundation for present R&D
The R&D portfolio now active under TEHNOFARM® — six pharmaceutical origin programmes, the dual-line ERINIUM® formulation work, the curated NATUR-FARMA® consumer pharmacy, the VESSENSE® cosmetic and wellness platform, the DMT DIVINEMINDTHERAPY® B2B raw-materials platform, and the T.E.H.N.O.F.A.R.M. OS medical autonomy programme — exists in a workable form because thirty-three years of accumulated infrastructure makes it possible to do this kind of work in Moldova at all.
What this page does not claim
This page does not enumerate operational specifics from earlier decades. The company's working position is that early operational details are not the relevant proof; the relevant proof is the present R&D portfolio and the documented IP, regulatory, and brand infrastructure that supports it. Heritage is the foundation. The work is what is built on it.
Industry of Advanced Pharmaceutical Technologies · EST. 1992